PharmaOasis guides pharmaceutical firms through complex Middle East and GCC regulatory affairs, offering tailored strategies, dossier management, and compliance expertise for seamless market entry and ongoing safety.
Your Gateway to Middle East and GCC Regulatory Affairs: A Comprehensive Guide Read More »
Middle East and GCC pharma regulations are rapidly evolving with digital submissions, stricter pharmacovigilance, biotech scrutiny, and tougher device registration, requiring strategic compliance and local expertise.
7 Emerging Trends in Middle Eastern and GCC Pharma Regulations to Watch Now Read More »
Best practices for medical device lifecycle management in the Middle East and GCC include understanding country-specific regulations, implementing ISO 13485 QMS, ensuring Arabic labeling, post-market vigilance, and securing licensed distributors for smooth market access.
GCC pharmaceutical regulations are evolving with centralized registration, stricter Saudi SFDA/UAE MoHAP policies, enhanced pharmacovigilance, digital submissions, and growing use of real-world evidence.
Emerging Trends Shaping Pharmaceutical Regulations in the GCC and Middle East Read More »
